GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a major focus in medical studies, largely due to its remarkable impact on managing ailments such as type 2 diabetes and obesity. New studies have demonstrated that beyond glucose control, GLP-1 medications offer promise for cardiovascular well-being and even brain disorders